Among the 999 patients eligible in this study, patients were excluded if they did not have AST/ALT value results before TKI administration (n = 72), if they had elevated AST/ALT before TKI administration (n = 123), and if they already had underlying liver disease (n = 101). Here, GPT is linked to liver disorder.